The invention relates to the field of medicine, specifically to the field oftreatment of conditions associated withStaphylococcus infection. The invention relates to a novel endolysinpolypeptide specifically targeting a bacterial Staphylococcus cell.The invention further relates to said endolysin polypeptide for medical use,preferably for treating an individual suffering from acondition associated with Staphylococcus infection.